In 2023, South Korea had the highest rate of hospital discharges for malignant neoplasm of the ovary, at 143.8 discharges per hundred thousand persons, followed by Bulgaria at 73.0 and Poland at 69.1. Other notable countries included Ireland, Italy, France, and Spain, ranging between 20.8 and 23.7, with Portugal and Mexico having the lowest rates. Among observed year-on-year variations, Poland saw an increase of 4.03%, and South Korea rose by 2.26%, while others like Ireland and Italy experienced declines.
Future trends to watch include potential healthcare policy changes in these countries and advancements in ovarian cancer treatments, which could impact hospital discharge rates. Monitoring ongoing healthcare improvements and preventative measures will be key in predicting future trends.
Top countries in Hospital Discharges for Malignant Neoplasm of Ovary by Country
| # | 9 Countries | Units (Hospital Discharges) Per Hundred Thousand Persons | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 143.8 | 2023 | +3.01% | +2.26% | View data |
| 2 | 2 Bulgaria | 73 | 2021 | View data | ||
| 3 | 3 Poland | 69.1 | 2023 | +4.07% | +4.03% | View data |
| 4 | 4 Ireland | 23.7 | 2023 | +2.16% | -1.53% | View data |
| 5 | 5 Italy | 22.3 | 2023 | -0.45% | -1.54% | View data |
| 6 | 6 France | 21.1 | 2023 | 0% | -1.19% | View data |
| 7 | 7 Spain | 20.8 | 2023 | 0% | -0.38% | View data |
| 8 | 8 Portugal | 13.5 | 2021 | +1.5% | View data | |
| 9 | 9 Mexico | 10.5 | 2023 | +6.06% | -0.38% | View data |
